| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ONCONOVA THERAPEUTICS INC | 200 | 1,000 | 0.00% | ||
| 2 | CHECK CAP LTD | 53,488 | 5,000 | 0.00% | ||
| 3 | AKARI THERAPEUTICS PLC | 458 | 6,000 | 0.00% | ||
| 4 | ENTEROMEDICS INC | 33,334 | 10,000 | 0.01% | ||
| 5 | Aldeyra Therapeutics Inc | 2,499 | 14,000 | 0.01% | ||
| 6 | ANTARES PHARMA INC | 45,000 | 47,000 | 0.04% | ||
| 7 | GENVEC INC | 95,800 | 55,000 | 0.04% | SH | |
| 8 | CEL SCI CORP | 127,482 | 59,000 | 0.05% | ||
| 9 | Nivalis Therapeutics Inc | 15,000 | 69,000 | 0.05% | ||
| 10 | CATALYST | 70,903 | 108,000 | 0.09% | ||
| 11 | Marinus Pharmaceuticals Inc | 90,237 | 115,000 | 0.09% | ||
| 12 | CHECK CAP LTD | 88,220 | 123,000 | 0.10% | ||
| 13 | CASCADIAN THERAPEUTICS INC | 175,000 | 165,000 | 0.13% | ||
| 14 | VistaGen Therapeutics Inc | 46,900 | 183,000 | 0.15% | ||
| 15 | AKEBIA THERAPEUTICS INC | 24,700 | 185,000 | 0.15% | ||
| 16 | ADAPTIMMUNE THERAPEUTICS PLC | 24,955 | 203,000 | 0.16% | ||
| 17 | GLYCOMIMETICS INC | 27,996 | 204,000 | 0.16% | ||
| 18 | TENAX THERAPEUTICS INC | 79,509 | 204,000 | 0.16% | ||
| 19 | BLUEPRINT MEDICINES CORP COM | 10,100 | 205,000 | 0.16% | ||
| 20 | Sunesis Pharmaceuticals I | 423,336 | 232,000 | 0.18% | ||
| 21 | NEURODERM LTD | 14,421 | 234,000 | 0.19% | ||
| 22 | AVEO PHARMACEUTICALS INC | 259,067 | 249,000 | 0.20% | SH | |
| 23 | NEMUS BIOSCIENCE INC | 511,508 | 252,000 | 0.20% | ||
| 24 | DEXTERA SURGICAL INC | 140,275 | 252,000 | 0.20% | ||
| 25 | ARBUTUS BIOPHARMA CORP | 75,000 | 261,000 | 0.21% | ||
| 26 | ARDELYX INC COM | 30,000 | 262,000 | 0.21% | SH | |
| 27 | COGENTIX MED INC | 352,882 | 339,000 | 0.27% | ||
| 28 | DICERNA PHARMACEUTICALS INC | 119,300 | 358,000 | 0.28% | ||
| 29 | Pieris Pharmaceuticals | 223,325 | 360,000 | 0.29% | ||
| 30 | NEOS THERAPEUTICS INC COM | 38,873 | 361,000 | 0.29% | ||
| 31 | VTV THERAPEUTICS INC | 73,000 | 423,000 | 0.34% | ||
| 32 | ABEONA THERAPEUTICS INC | 181,818 | 429,000 | 0.34% | ||
| 33 | ADVERUM BIOTECHNOLOGIES INC | 140,600 | 444,000 | 0.35% | ||
| 34 | TETRAPHASE PHARMACEUTICALS INC COM | 103,690 | 446,000 | 0.35% | ||
| 35 | BLUEBIRD BIO INC COM | 12,000 | 519,000 | 0.41% | SH | |
| 36 | MASIMO CORP | 10,000 | 525,000 | 0.42% | SH | |
| 37 | TARGACEPT INC | 530,821 | 531,000 | 0.42% | PRN | |
| 38 | INTEC PHARMA LTD JERUSALEM | 119,296 | 549,000 | 0.44% | ||
| 39 | INNOCOLL HLDGS PLC | 100,000 | 551,000 | 0.44% | ||
| 40 | CYNAPSUS THERAPEUTICS INC | 33,995 | 564,000 | 0.45% | SH | |
| 41 | SCYNEXIS INC | 266,904 | 579,000 | 0.46% | SH | |
| 42 | BEIGENE LTD | 20,000 | 596,000 | 0.47% | ||
| 43 | IRONWOOD PHARMACEUTICALS INC DBCV 2.250 6/1 | 600,000 | 620,000 | 0.49% | PRN | |
| 44 | SYNERON MEDICAL LTD | 85,947 | 661,000 | 0.52% | SH | |
| 45 | Ascendis Pharma | 53,241 | 707,000 | 0.56% | ||
| 46 | CONCERT PHARMACEUTICALS INCORPORATED | 66,968 | 752,000 | 0.60% | ||
| 47 | GERON CORP | 285,000 | 764,000 | 0.61% | ||
| 48 | ESSA Pharma | 202,496 | 810,000 | 0.64% | ||
| 49 | MINERVA NEUROSCIENCES INC COM | 80,100 | 818,000 | 0.65% | ||
| 50 | Exactech Inc | 31,636 | 846,000 | 0.67% | SH |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001389933-16-000031, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
